Key result
This review discusses anticoagulant agents used for deep-vein thrombosis prophylaxis in orthopaedic patients and identifies nursing responsibilities for patient care and education.
This article reviews anticoagulant agents used for DVT prophylaxis in orthopaedic surgery patients and identifies nursing responsibilities for patient care and education.
May inform nursing education on anticoagulants for orthopaedic DVT prophylaxis; leaves open need for prospective outcome studies.
Deep-vein thrombosis (DVT) is a serious and complicated aspect of orthopaedic surgery, especially in surgery that involves hip and knees. The possibility of pulmonary embolism as a consequence of DVT is life-threatening and the costs associated with treating DVT are enormous. The emotional consequences of pain, extended isolation, and impaired social interaction impact every aspect of the lives of patients with DVT. Since the signs and symptoms of DVT are nonspecific and treatment may be delayed until complications arise, prevention of DVT with prophylactic therapy is often the chosen route of post-surgical care. In this article anticoagulant agents used in DVT prophylaxis are discussed and nursing responsibilities for patient care and education are identified.
No takes yet. Share an insight, caveat, or question.
Beatrice B. Turkoski (2000) conducted a review in Deep-vein thrombosis in orthopaedic surgery. Anticoagulant agents was evaluated. This review discusses anticoagulant agents used for deep-vein thrombosis prophylaxis in orthopaedic patients and identifies nursing responsibilities for patient care and education.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: